Skip to content
Search

Latest Stories

Tennis champion Monica Seles reveals living with myasthenia gravis

This causes muscle weakness and can affect multiple parts of the body

Monica Seles

Seles first began noticing symptoms around five years ago

Getty Images
Gayathri Kallukaran
By Gayathri KallukaranAug 13, 2025
Gayathri Kallukaran
Gayathri Kallukaran is a Junior Journalist with Eastern Eye. She has a Master’s degree in Journalism and Mass Communication from St. Paul’s College, Bengaluru, and brings over five years of experience in content creation, including two years in digital journalism. She covers stories across culture, lifestyle, travel, health, and technology, with a creative yet fact-driven approach to reporting. Known for her sensitivity towards human interest narratives, Gayathri’s storytelling often aims to inform, inspire, and empower. Her journey began as a layout designer and reporter for her college’s daily newsletter, where she also contributed short films and editorial features. Since then, she has worked with platforms like FWD Media, Pepper Content, and Petrons.com, where several of her interviews and features have gained spotlight recognition. Fluent in English, Malayalam, Tamil, and Hindi, she writes in English and Malayalam, continuing to explore inclusive, people-focused storytelling in the digital space.
See Full Bio
Follow:

Highlights:

  • Nine-time Grand Slam winner Monica Seles diagnosed with myasthenia gravis three years ago
  • The 51-year-old revealed her condition ahead of this month’s US Open to raise awareness
  • Disease causes muscle weakness and has no known cure

Former world number one Monica Seles has revealed she was diagnosed with myasthenia gravis, a rare neuromuscular autoimmune disease, three years ago. The 51-year-old, who won nine Grand Slam singles titles, went public ahead of the US Open to raise awareness of the condition, which causes muscle weakness and can affect multiple parts of the body.

Symptoms and diagnosis

Seles first began noticing symptoms around five years ago when she experienced double vision and struggled with coordination. “I would be playing [tennis] with some kids or family members, and I would miss a ball. I was like, ‘Yeah, I see two balls,’” she told the Associated Press. These symptoms eventually led to her diagnosis, which took time for her to come to terms with.

Living with the condition

The former tennis star described the impact of the disease on her daily life as “significant” and said it was initially difficult to discuss openly. Myasthenia gravis currently has no cure, but treatments can help manage its effects. By sharing her experience, Seles hopes to use her platform to educate others.

Career highlights

Seles rose to prominence as a teenager, winning her first Grand Slam at the 1990 French Open aged 16 and claiming eight majors by 19. Her career was interrupted in 1993 when she was stabbed by a spectator during a match in Hamburg. She returned to the sport and won one more Grand Slam before retiring in 2003, having spent 178 weeks as world number one and capturing 53 career titles.

monica selesneuromuscular conditiontennis championmyasthenia gravishealthtennis

Related News

Oklahoma, not Las Vegas, holds the title of America’s casino capital
Lifestyle

Oklahoma, not Las Vegas, holds the title of America’s casino capital

What esports and football have in common
Sports

What esports and football have in common

Woakes eyes rehab over surgery for Ashes return
Cricket

Woakes eyes rehab over surgery for Ashes return

'Sexism, transphobia and faith abuse rise in UK football'
Football

'Sexism, transphobia and faith abuse rise in UK football'

More For You

faulty knee implant NHS recall

Hundreds of patients required corrective surgery

iStock

Faulty knee implant recalled after being used in over 10,000 NHS surgeries

Highlights:

  • NexGen knee implant linked to high failure rates was used in over 10,000 UK operations.
  • Concerns flagged as early as 2014; withdrawn from UK market in 2022.
  • Hundreds of patients required corrective surgery, with costs running into millions.
  • Manufacturer Zimmer Biomet says patient safety is its “top priority” but will not cover revision costs up front.

Implant used despite early warnings

A knee replacement implant used in thousands of NHS operations was known to have a concerning failure rate eight years before it was withdrawn, a BBC File on 4 Investigates report has found.

The NexGen implant, made by US manufacturer Zimmer Biomet, was fitted in more than 10,000 patients between 2012 and 2022. Concerns were first raised by the National Joint Registry (NJR) in 2014, though insufficient data at the time made it difficult to draw firm conclusions.

Keep ReadingShow less
health

A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV

iStock

Oral sex linked to skin cancer risk through stealth HPV infections, scientists warn

Highlights:

  • HPV, a common STI, is now potentially linked to a deadly form of skin cancer
  • A 34-year-old woman developed 43 aggressive skin cancer lesions triggered by HPV
  • Researchers say this discovery could shift the approach to diagnosing and treating some skin cancers
  • Protection measures include vaccination, safe sex practices, and regular screening


Human papillomavirus (HPV), one of the most widespread sexually transmitted infections in the UK, is already associated with several serious cancers — cervical, throat, penile, anal, and head and neck cancers among them. Now, researchers in the US have raised concerns that it may also contribute to certain forms of skin cancer, especially in people with weakened immune systems.

Scientists from the National Institutes of Health (NIH) found signs of beta-HPV triggering squamous cell carcinoma in a young woman who had no major history of sun damage or other typical causes.

Keep ReadingShow less
CardioPrecision

The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes

MediaZoo

CardioPrecision performs world-first robot-assisted aortic valve replacement via neck incision

Highlights:

  • Glasgow-based CardioPrecision completes first clinical cases of robotic aortic valve replacement (AVR) through a small neck incision.
  • The procedure was carried out at Cleveland Clinic in the United States.
  • It uses the company’s CoreVista® Robot Enabling Platform to perform minimally invasive surgery.
  • The approach aims to reduce pain, shorten hospital stays, and improve patient outcomes.
  • Early results presented at major international conferences show clinical promise.


Glasgow medtech firm CardioPrecision has successfully performed the world’s first clinical cases of robot-assisted aortic valve replacement (AVR) using a small transcervical incision. This breakthrough could significantly reduce the need for traditional open-heart surgery.

The pioneering operations were carried out at the Cleveland Clinic in the United States, a centre globally recognised for its cardiovascular care. The procedures used CardioPrecision’s proprietary CoreVista® Robot Enabling Platform, offering a new route for accessing the heart valve via the neck rather than the chest.

Keep ReadingShow less
Chikungunya outbreak China 2025

Chikungunya is not contagious between people

Getty Images

Chikungunya virus outbreak in China: What you need to know

Highlights:

  • Over 7,000 chikungunya cases reported in southern China, mainly Guangdong province
  • Virus spread rapidly after an imported case was detected in Foshan on 8 July
  • Authorities enforcing hospital quarantine and door-to-door inspections
  • Chikungunya is mosquito-borne and not transmitted person to person
  • CDC issues travel alert; UK yet to release guidance

A mosquito-borne virus is spreading rapidly in China, with more than 7,000 people infected across at least 13 cities in Guangdong province. Authorities are introducing containment measures reminiscent of the Covid pandemic in an effort to stop the virus’s spread—even though chikungunya cannot be transmitted between people.

The outbreak began in Foshan, north of Hong Kong, where an imported case was confirmed on 8 July. The city has since recorded nearly 3,000 cases in just one week, according to Chinese media and international reporting.

Keep ReadingShow less
Mounjaro

Long-term lifestyle changes and support are essential for sustained weight loss

iStock

Mounjaro patients need more support after treatment, health experts say

Highlights:

  • NICE warns that patients risk regaining weight after stopping jabs like Mounjaro and Wegovy
  • NHS patients should receive structured support for at least a year after treatment
  • Private users, who make up the majority, are not eligible for NHS follow-up
  • Around 240,000 NHS patients will receive Mounjaro over the next three years
  • Long-term lifestyle changes and support are essential for sustained weight loss


Patients using popular weight-loss jabs, including Mounjaro (tirzepatide), are being warned about the risk of regaining weight once treatment ends. The National Institute for Health and Care Excellence (NICE) is urging health services to provide structured support and follow-up care, particularly for those accessing the drugs via the NHS.

New guidance from NICE stresses the importance of offering advice and continued monitoring to prevent weight gain after medication ends, stating that patients should not be left without support during this crucial transition period.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Asian Media Group USA Inc
Contact Us